Literature DB >> 14704913

Diabetes has an additive effect on neural apoptosis in rat retina with chronically elevated intraocular pressure.

Akiyasu Kanamori1, Makoto Nakamura, Hirokazu Mukuno, Hidetaka Maeda, Akira Negi.   

Abstract

PURPOSE: Diabetes mellitus (DM) is a risk factor for open-angle glaucoma, although the mechanistic interrelationship of the two is debatable. The purpose of this study is to test whether DM augments neural apoptosis in rat retina with chronically elevated intraocular pressure (IOP).
METHODS: Sprague-Dawley rats were made diabetic by intraperitoneal injection of streptozotocin (STZ). At one month after STZ injection, three episcleral veins in one eye were cauterized to elevate IOP. Rats without STZ injection were treated likewise as diabetic controls. At 2 weeks, 1 month, and 2 months after cauterization, the retina was dissected, flat-mounted, and subjected to terminal dUTP nick end labeling (TUNEL) staining. TUNEL positive cells per unit area of the whole retina were measured.
RESULTS: DM did not affect base line IOP or augment IOP elevation due to episcleral vein cauterization. TUNEL positive cells, which primarily consisted of the neurons and glial cells in the inner retina including retinal ganglion cell (RGC), were counted consistently eight times more in the diabetic retina without IOP elevation than diabetic controls (n = 9, p < 0.001). The cauterization significantly elevated IOP up to 28.9 mmHg (p < 0.001), which was reduced over time, and substantially induced apoptosis in a IOP-dependent fashion (p < 0.001). Ocular hypertensive retinas with DM had significantly more TUNEL positive cells than those without DM despite of the similar time course of IOP changes (p < 0.001).
CONCLUSIONS: DM has an additive effect on apoptosis induction by chronic elevation of IOP. Diabetes may act as a risk factor of open-angle glaucoma by increasing susceptibility of retinal cells including retinal ganglion cells to apoptosis triggered by additional stresses such as elevated IOP.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14704913     DOI: 10.1076/ceyr.28.1.47.23487

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  24 in total

Review 1.  Retinal Neurodegeneration as an Early Manifestation of Diabetic Eye Disease and Potential Neuroprotective Therapies.

Authors:  Sidra Zafar; Mira Sachdeva; Benjamin J Frankfort; Roomasa Channa
Journal:  Curr Diab Rep       Date:  2019-02-26       Impact factor: 4.810

2.  A prospective study of diabetes, lifestyle factors, and glaucoma among African-American women.

Authors:  Lauren A Wise; Lynn Rosenberg; Rose G Radin; Cynthia Mattox; Erynn B Yang; Julie R Palmer; Johanna M Seddon
Journal:  Ann Epidemiol       Date:  2011-06       Impact factor: 3.797

3.  Diabetes and risk of glaucoma: systematic review and a Meta-analysis of prospective cohort studies.

Authors:  Ying-Xi Zhao; Xiang-Wu Chen
Journal:  Int J Ophthalmol       Date:  2017-09-18       Impact factor: 1.779

Review 4.  Ocular complications of diabetes mellitus.

Authors:  Nihat Sayin; Necip Kara; Gökhan Pekel
Journal:  World J Diabetes       Date:  2015-02-15

Review 5.  The significance of vascular and neural apoptosis to the pathology of diabetic retinopathy.

Authors:  Alistair J Barber; Thomas W Gardner; Steven F Abcouwer
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-02-28       Impact factor: 4.799

6.  Type 2 diabetes mellitus and the risk of open-angle glaucoma the Los Angeles Latino Eye Study.

Authors:  Vikas Chopra; Rohit Varma; Brian A Francis; Joanne Wu; Mina Torres; Stanley P Azen
Journal:  Ophthalmology       Date:  2007-08-22       Impact factor: 12.079

7.  Attenuation of diabetes-induced retinal vasoconstriction by a thromboxane receptor antagonist.

Authors:  William S Wright; Jodine E Messina; Norman R Harris
Journal:  Exp Eye Res       Date:  2008-11-01       Impact factor: 3.467

8.  Pathophysiological characteristics of diabetic ocular complications in spontaneously diabetic torii rat.

Authors:  Tomohiko Sasase
Journal:  J Ophthalmol       Date:  2010-05-25       Impact factor: 1.909

9.  Ozagrel attenuates early streptozotocin-induced constriction of arterioles in the mouse retina.

Authors:  William S Wright; Norman R Harris
Journal:  Exp Eye Res       Date:  2008-01-09       Impact factor: 3.467

Review 10.  Myopia and diabetes mellitus as modificatory factors of glaucomatous optic neuropathy.

Authors:  Etsuo Chihara
Journal:  Jpn J Ophthalmol       Date:  2013-08-15       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.